We are proud to announce that on October 26th we participated in the symposium “Global perspectives for atopic dermatitis, united for better care” organized by ISAD (the International Society for Atopic Dermatitis).
On this occasion, during our presentation, we were able to present the results of the clinical study supporting the good compliance of a topical emulsion developed by Inves Biofarm for the treatment of atopic dermatitis (AD).
We will continue to provide innovative and high quality solutions for the research and development of dermatological diseases through topical formulations based on our patented biotechnological solution.
